drugset / Trial / NCT05797662
A Study of Propranolol to Treat Kaposi Sarcoma
NaSingle-groupOpen-labelTreatment
Summary
A clinical study of propranolol for the treatment of Kaposi Sarcoma in children and adults. This study will be an open-label single armed treatment trial that will test the effectiveness and the safety of treating Kaposi Sarcoma with propranolol.
Timeline
- Start
- 2026-08-31
- Primary completion
- 2028-09
- Completion
- 2029-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propranolol | Small molecule | 3 mg/kg | Oral |
| Subject | Propranolol | Small molecule | 120 mg | Oral |